Marc Tischkowitz

Tischkowitz completed a Bachelor of Medicine, Bachelor of Surgery at University of Liverpool in 1993. He undertook residencies in Medical Oncology and Clinical Genetics, obtaining a Certificate of Completion of Specialist Training in Clinical Genetics. In 1999, he began doctoral studies researching chromosome breakage syndrome, fanconi anemia, gene mutations, and acute myeloid leukemia.[1][2] He earned a Ph.D. from King's College, London.[1][3] His 2003 dissertation was titled The role of mutations in Fanconi Anaemia genes in the aetiology of acute myeloid leukaemia and solid tissue malignancies.[3]

After completing his certification in 2004 Tischkowitz was appointed as an NHS Consultant at Great Ormond Street HospitalLondon. In 2005, he joined McGill University Faculty of Medicine as an assistant professor in the departments of Human Genetics, Oncology, and Medicine.[1] He gained tenure and was promoted to Associate Professor in 2011. While at McGill, he was an attending physician at the Jewish General Hospital and McGill University Health Centre.[2] After six years in Montreal, Tischkowitz joined the School of Clinical Medicine, University of Cambridge where he is Professor of Medical Genetics in the Academic Department of Medical Genetics and an honorary NHS Consultant for the East Anglian Medical Genetics service.[1] From 2018-20, he was editor-in-chief of Genetics Research and in 2022 he was appointed editor-in-chief of BJC Reports, a new sister journal to British Journal of Cancer. He is the former Chair of the UK Cancer Genetics Group and was an executive member of the GENTURIS European Reference Network for rare hereditary tumour syndromes.

• Marc Tischkowitz publications indexed by Google Scholar